Aerie Pharmaceuticals (Germany) Profile

EUR 1  2.11%

Aerie Pharmaceuticals Summary

Aerie Pharmaceuticals Inc (0P0) is traded on Frankfurt Stock Exchange in Germany. and employs 13 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.85 B. Aerie Pharmaceuticals Inc has 36.43 M outstanding shares. AERIE PHARMACEUT has accumulated about 281.33 M in cash with (85.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.66.
Check Aerie Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Aerie Pharmaceuticals Inc Risk Profiles

Key Fundamentals

Aerie Pharmaceuticals Against Markets

Current Ratings

Aerie Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 32% 
Equity ratings for Aerie Pharmaceuticals Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Aerie Pharmaceuticals is entity of Germany. It is traded as Stock on FRA exchange. more
NameAerie Pharmaceuticals Inc
Macroaxis Advice
InstrumentGermany Stock Stocks Directory
ExchangeFrankfurt Stock Exchange
CurrencyEUR - Euro


Aerie Pharmaceuticals Corporate Directors
Julie McHugh Independent Director, MBA
Benjamin McGraw Independent Director, Ph.D
Anand Mehra Director, Ph.D


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas